VitroScan is presenting at SITC 2025

15 October 2025

Felix Behr will be presenting data of VitroScan's recent study. The poster is titled "on ex vivo micro-tumor testing identifies patient-specific anti-tumor immune responses to T cell engager ubamatamab" which will be available for download from the insights section on the website after the conference.